Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy (HOPPE)
Enoxaparin for the Prevention of Placental-Mediated Complications of Pregnancy in Women With Obstetric History or Abnormal Uterine Artery Doppler at First Trimester Ultrasound and Without Thrombophilia: a Multicenter Randomized Controlled Trial
Sponsor: Hospital Sant Joan de Deu
This PHASE3 trial investigates High Risk Pregnant Women and Placental Insufficiency and is currently completed. Hospital Sant Joan de Deu leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Sep 2020 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Sant Joan de Deu
- Hospital Universitari Vall d'Hebron Research Institute
- Hospital Vall d'Hebron
- Hospital de Cruces
- Parc Sanitari Sant Joan de Déu
For direct contact, visit the study record on ClinicalTrials.gov .